Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atacand for Diabetic Retinopathy Prevention in Type 1 Diabetes (DIRECT-Prevent 1)
NCT00252733Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2001
- Primary completion
- Apr 2008
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 2
01
Overview
Phase 3 trial of candesartan, sponsored by AstraZeneca. Started Jun 2001; status: completed.
02
Drugs
candesartan
Beyond the preview
Go deeper on NCT00252733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00252733.